Pharmaceutical medicine

Keyphrases

Publications

2023

Abdul Wahab, Attiya Iqbal
Black-Box Warnings of Antiseizure Medications: What is Inside the Box? Pharmaceutical medicine (2023)
Khoi Than, Lori Salamida
How Digital Opinion Leaders (DOLs) in Clinical Care are Changing the Medical Landscape. Pharmaceutical medicine (2023)
Amit Dang
Real-World Evidence: A Primer. Pharmaceutical medicine (2023)
Mirjam Wolfschlag, Anders Håkansson
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management. Pharmaceutical medicine (2023)
Lisa Gieber, Vincent Muturi-Kioi, Shelly Malhotra, Ayesha Sitlani
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond. Pharmaceutical medicine (2023)
Neil McAuslane, Magda Bujar, Tariro Sithole, Nancy Ngum, Mercy Owusu-Asante, Stuart R Walker
Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities. Pharmaceutical medicine (2023)
Jean-Christophe Bélisle-Pipon, Pierre-Marie David
Digital Therapies (DTx) as New Tools within Physicians' Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use. Pharmaceutical medicine (2023)
Stuart D Faulkner, Fabian Somers, Mathieu Boudes, Begõna Nafria, Paul Robinson
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions. Pharmaceutical medicine (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine (2023)
Lisa Gieber, Vincent Muturi-Kioi, Shelly Malhotra, Ayesha Sitlani
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond. Pharmaceutical medicine (2023)
Khoi Than, Lori Salamida
How Digital Opinion Leaders (DOLs) in Clinical Care are Changing the Medical Landscape. Pharmaceutical medicine (2023)
Ranjana Pathak, Vaibhav Gaur, Himanshu Sankrityayan, Jaideep Gogtay
Tackling Counterfeit Drugs: The Challenges and Possibilities. Pharmaceutical medicine (2023)
Amit Dang
Real-World Evidence: A Primer. Pharmaceutical medicine (2023)
Khoi Than, Lori Salamida
How Digital Opinion Leaders (DOLs) in Clinical Care are Changing the Medical Landscape. Pharmaceutical medicine (2023)
Barbara A Hendrickson, Anupam Agarwal, Dimitri Bennett, Jürgen Kübler, Cynthia McShea, Lothar Tremmel
Value and Implementation of the Aggregate Safety Assessment Plan. Pharmaceutical medicine (2023)
Stuart D Faulkner, Fabian Somers, Mathieu Boudes, Begõna Nafria, Paul Robinson
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions. Pharmaceutical medicine (2023)
Sajad Khiali, Amin Agabalazadeh, Hadi Sahrai, Hossein Bannazadeh Baghi, Gholamreza Rahbari Banaeian, Taher Entezari-Maleki
Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review. Pharmaceutical medicine (2023)
Naohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, Sven Demiya
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review. Pharmaceutical medicine (2023)
Susan Mohamed, Sarah Dunnett, Angela Flores, Eva Loew, Stefne Pienaar, null null
A Principles Framework for Digital Provision of Medical Information for Healthcare Professionals. Pharmaceutical medicine (2023)
Rohita Sharma, Sumaira Ahmed, Judy Campagnari, Wendi Huff, Lelainia Lloyd
Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem. Pharmaceutical medicine (2023)
Mirjam Wolfschlag, Anders Håkansson
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management. Pharmaceutical medicine (2023)
Naohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, Sven Demiya
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review. Pharmaceutical medicine (2023)
Ranjana Pathak, Vaibhav Gaur, Himanshu Sankrityayan, Jaideep Gogtay
Tackling Counterfeit Drugs: The Challenges and Possibilities. Pharmaceutical medicine (2023)
Andriani C Patera, Julie Maidment, Brijesh Maroj, Ahmed Mohamed, Ken Twomey
A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials. Pharmaceutical medicine (2023)
Kampadilemba Ouoba, Hélène Lehmann, Arsene Zongo, Jean-Yves Pabst, Rasmané Semdé
Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries. Pharmaceutical medicine (2023)
Pete Guillot, John Shea, Scarlett Shoemaker, Michael Rocco, Michael DeLuca, Rena Rai, Evelyn R Hermes-DeSantis
Medical Information Delivering Improved Customer Experience: A Guide. Pharmaceutical medicine (2023)
Eddie G M Power
Considerations for Effective Communication of Medical Information. Pharmaceutical medicine (2023)
Carl Naraynassamy
The Central Role of Ethics in Medical Affairs Practice. Pharmaceutical medicine (2023)
Daniela R Junqueira, Dimitri Bennett, Susanna Y Huh, Carolina Casañas I Comabella
Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature Review. Pharmaceutical medicine (2023)
Eddie G M Power
Considerations for Effective Communication of Medical Information. Pharmaceutical medicine (2023)
Zhixing Yao, William V McCall
Designing Clinical Trials to Assess the Impact of Pharmacological Treatment for Suicidal Ideation/Behavior: Issues and Potential Solutions. Pharmaceutical medicine (2023)
Amit Dang
Real-World Evidence: A Primer. Pharmaceutical medicine (2023)

volume 37, number 1, 2023

Naohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, Sven Demiya
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review. Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Mirjam Wolfschlag, Anders Håkansson
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management. Pharmaceutical medicine 37 (1) (2023)
Amit Dang
Real-World Evidence: A Primer. Pharmaceutical medicine 37 (1) (2023)
Mirjam Wolfschlag, Anders Håkansson
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management. Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Naohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, Sven Demiya
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review. Pharmaceutical medicine 37 (1) (2023)
Mirjam Wolfschlag, Anders Håkansson
Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management. Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Naohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, Sven Demiya
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review. Pharmaceutical medicine 37 (1) (2023)
Amit Dang
Real-World Evidence: A Primer. Pharmaceutical medicine 37 (1) (2023)
Amit Dang
Real-World Evidence: A Primer. Pharmaceutical medicine 37 (1) (2023)
Naohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, Sven Demiya
Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review. Pharmaceutical medicine 37 (1) (2023)

volume 37, number 3, 2023

Abdul Wahab, Attiya Iqbal
Black-Box Warnings of Antiseizure Medications: What is Inside the Box? Pharmaceutical medicine 37 (3) (2023)
Lisa Gieber, Vincent Muturi-Kioi, Shelly Malhotra, Ayesha Sitlani
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond. Pharmaceutical medicine 37 (3) (2023)
Khoi Than, Lori Salamida
How Digital Opinion Leaders (DOLs) in Clinical Care are Changing the Medical Landscape. Pharmaceutical medicine 37 (3) (2023)
Andriani C Patera, Julie Maidment, Brijesh Maroj, Ahmed Mohamed, Ken Twomey
A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials. Pharmaceutical medicine 37 (3) (2023)